PSC
CMRX

Piper Sandler & Co’s Chimerix, Inc. CMRX Stock Holding History

Piper Sandler & Co’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-22
Closed – – 27
2015
Q4 		$0 Buy
+22
New +$792 ﹤0.01% 72
2014
Q1 		– Sell
-21,250
Closed -$321K – 125
2013
Q4 		$321K Buy
+21,250
New +$339K 0.27% 54

Other funds holding CMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Piper Sandler & Co's CMRX Position: Q1 2016 in Review

Piper Sandler & Co sold out of Chimerix, Inc. (CMRX) in Q1 2016, closing a stake of 22 shares.

Piper Sandler & Co first reported a position in CMRX in Q4 2013 and held it in 2 quarters. The position peaked at $321K in Q4 2013. 123 funds tracked by Wall St. Rank hold CMRX as of Q1 2016.

  • Piper Sandler & Co reported no remaining Chimerix, Inc. position as of Q1 2016 after selling out during the quarter.
  • Piper Sandler & Co sold 22 Chimerix, Inc. shares in Q1 2016.
  • Piper Sandler & Co first reported a position in Chimerix, Inc. in Q4 2013 and held it in 2 quarters.
  • Piper Sandler & Co's Chimerix, Inc. position peaked at $321K in Q4 2013.
  • 123 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2016.

Based on Piper Sandler & Co's 13F filing for Q1 2016, filed 16 May 2016.